Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Sarepta Therapeutics, Inc."
Count: 40
Selected: 0
NCT IDTitle
NCT03532542An Extension Study to Evaluate Casimersen or Golodirsen in Patients With Duchenne Muscular Dystrophy
NCT02500381Study of SRP-4045 and SRP-4053 in Participants With Duchenne Muscular Dystrophy (DMD)
NCT04626674A Gene Delivery Study to Evaluate the Safety of and Expression From SRP-9001 in Duchenne Muscular Dystrophy (DMD)
NCT04475926A Study of the Natural History of Patients With LGMD2E/R4, LGMD2D/R3, and LGMD2C/R5, ≥ 4 Years of Age, Who Are Managed in Routine Clinical Practice
NCT03652259Gene Delivery Clinical Trial of SRP-9003 for Participants With Limb-Girdle Muscular Dystrophy, Type 2E (LGMD2E) (Beta-Sarcoglycan Deficiency)
NCT02530905Dose-Titration and Open-label Extension Study of SRP-4045 in Advanced Stage Duchenne Muscular Dystrophy (DMD) Patients
NCT02710500rAAVrh74.MHCK7.DYSF.DV for Treatment of Dysferlinopathies
NCT03675126An Open-Label Extension Study for Patients With Duchenne Muscular Dystrophy Who Participated in Studies of SRP-5051
NCT04004065Study for Dose Determination of SRP-5051, Then Dose Expansion in Patients With Duchenne Muscular Dystrophy Amenable to Exon 51-Skipping Treatment
NCT03218995Study of Eteplirsen in Young Patients With DMD Amenable to Exon 51 Skipping
NCT02420379Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy
NCT02255552Study of Eteplirsen in DMD Patients
NCT03769116A Randomized, Double-blind, Placebo-controlled Study of SRP-9001 for Duchenne Muscular Dystrophy (DMD)
NCT03992430A Study to Compare Safety and Efficacy of a High Dose of Eteplirsen in Duchenne Muscular Dystrophy (DMD) Patients (MIS51ON)
NCT03375164Systemic Gene Delivery Clinical Trial for Duchenne Muscular Dystrophy (DMD)
NCT02310906Phase I/II Study of SRP-4053 in DMD Patients
NCT03985878A Study to Evaluate Safety, Tolerability, and Efficacy of Eteplirsen in Patients With Duchenne Muscular Dystrophy
NCT03375255A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of a Single Dose of SRP-5051 in Patients With Duchenne Muscular Dystrophy (DMD)
NCT02286947Safety Study of Eteplirsen to Treat Advanced Stage Duchenne Muscular Dystrophy
NCT01540409Efficacy, Safety, and Tolerability Rollover Study of Eteplirsen in Subjects With Duchenne Muscular Dystrophy
NCT01396239Efficacy Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy Patients
NCT00844597Dose-Ranging Study of AVI-4658 to Induce Dystrophin Expression in Selected Duchenne Muscular Dystrophy (DMD) Patients
NCT01566877A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers
NCT01375985Safety Study of Single Administration Intravenous Treatment for Influenza
NCT01593072A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers
NCT01353040Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
NCT01353027Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus
NCT00451256Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG)
NCT00387283Pharmacokinetic Study in Cerebral Spinal Fluid After a Single Dose of AVI-4020
NCT00381433Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid
NCT00343148Pharmacokinetic Study of a Single Dose of AVI-4126 (RESTEN-NG®) in Cerebral Spinal Fluid
NCT00091845An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease
NCT00244647A Phase 1b Study Evaluating RESTEN-MP in Subjects With Focal de Novo Stenosis
NCT00229749Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients
NCT00248066Safety and Efficacy of RESTEN-MP When Used in Conjunction With a Bare Metal Stent in Coronary Arteries
NCT04708314An Open-Label Study of Golodirsen in Non-Ambulant Patients With Duchenne Muscular Dystrophy
NCT04179409A 48-Week, Open Label, Study to Evaluate the Efficacy and Safety of Casimersen, Eteplirsen and Golodirsen in Subjects With Duchenne Muscular Dystrophy Carrying Eligible DMD Duplications
NCT00159250Safety and Efficacy Study of Antisense Oligonucleotides in Duchenne Muscular Dystrophy
NCT03680365Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families
NCT03655223Early Check: Expanded Screening in Newborns